|
FOR
IMMEDIATE RELEASE
December
02 , 2005.
Guava
Technologies have introduced Caspase 3/7 and 8 Assay kits enabling
rapid and sensitive detection of the initial and mid-stages of programmed
cell death.
Rapid,
sensitive detection of Caspase enzyme activity in live cells ..
Guava
Technologies have introduced Caspase 3/7 and 8 Assay kits enabling
rapid and sensitive detection of the initial and mid-stages of programmed
cell death.
Designed
for use with the Guava EasyCyte benchtop microcytometry system,
the new fluorescence-based assays allow researchers to easily discriminate
between apoptotic and non-apoptotic cells based upon the simultaneous
interrogation of caspase activity and cell membrane permeability
within a single assay. The EasyCyte's 96-well microplate analysis
format enables a researcher to easily perform hundreds of cell-based
assays in a single day.

Suitable
for use with both adherent and suspension cells Guava Caspase assays
are ideally suited for applications in drug discovery and development.
They are sensitive enough to detect even naturally occuring apoptosis
at 2 - 6% of the overall population, while still delivering robust,
reproducible and specific detection of Caspase 3/7 or 8 enzyme activity.
Typically staining and data acquisition for a complete 96-well microplate
can be achieved in under 3 hours with the Caspase assay kits and
the Guava EasyCyte system's integrated ExpressPlus software.
The
new Guava Caspase assays run on the Guava EasyCyte, a compact and
flexible five-parameter system. Because only a few microlitres of
sample are required, the Guava EasyCyte saves precious and expensive
cells, reagents and compounds. The system is so easy to use that
results are generated with less than a day's training. The Guava
EasyCyte system runs each of Guava's turnkey assays, enabling fast
and easy measurements of cell counting/viability; GFP expression
and viability; apoptosis; cell cycle analysis; antigen detection;
cell tracking; and more.
Guava
Technologies, Inc., a privately held biotechnology and medical device
company, is the leading provider of on-demand, easy-to-use single
cell analysis systems. Guava Personal Cell Analysis (PCA™) systems,
including the Guava PCA, Guava PCA-96 and Guava EasyCyte systems,
are integrated, fully optimised, micro-capillary cytometry systems
with embedded absolute cell counting capability. Used worldwide
by the life sciences, biotechnology, and pharmaceutical industries,
as well as clinical testing institutions (outside the United States
and Europe), Guava's products have broad applications in scientific
research and throughout the drug discovery and lead optimisation
process, as well as for cell counting and optimisation of commercial
bio-pharmaceutical production. Guava offers a variety of assays
and dedicated software modules for the Guava PCA systems, enhancing
the system's overall ease-of-use. More information about the company
and its products is available at www.guavatechnologies.com
CONTACTS:
|